Pharmacokinetic studies live and die by the quality of their blood samples. To trace how a drug rises, peaks, and clears from the bloodstream, researchers must draw venous blood again and again at precisely timed intervals, and each additional puncture adds burden for participants and risk to the sampling schedule. A new pilot study suggests that a needle-free blood collection device can keep a single intravenous catheter working through an entire day of intensive sampling, potentially reshaping how early-phase drug research is conducted.
Office of Strategic Communication